Loading clinical trials...
Loading clinical trials...
The objective is to achieve 90% overall, positive and negative clinical concordance between results of the T-SPOT.TB assay, using cells isolated via density gradient centrifugation and positive select...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Oxford Immunotec
NCT04923958 · Tuberculosis
NCT06590428 · Rifampin-resistant Tuberculosis, Drug-resistant Tuberculosis
NCT06192160 · Pulmonary Tuberculosis
NCT05947890 · HIV I Infection, Tuberculosis
NCT05989802 · Tuberculosis, Diagnostics, and more
NECCR Primacare Research, LLC
Fall River, Massachusetts
Ohio State University
Columbus, Ohio
University of Texas Health Science Center at Houston, School of Public Health in Brownsville
Brownsville, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions